DEF Biologic & Small Molecule NP/PA CME Bootcamp Series 2024
BOOTCAMP SERIES UPDATED FOR 2024
The DEF Biologic & Small Molecule NP/PA CME Bootcamp Series is now more comprehensive than ever!
Join us for our West Coast, Live, In-Person CME Program
+
DEF Biologic & Small Molecule CME Bootcamp Virtual Program for the Advanced Learner, December 1, 2024
Stay tuned for more information and registration!
The ideal audience member will likely attend at least 2 of the Bootcamps, consisting of a basic-to-immediate course that is offered live on both the east and west coast and then moving to a more advanced learning program at the end of the year. At each meeting, the intended audience includes dermatology NPs, PAs, biologic coordinators, medical assistants, and their employing physicians. Increasing the agenda offerings also allows for a larger regional conference where attendees will travel by car, train, or plane to participate.
Join the Dermatology Education Foundation (DEF) for the DEF Biologic & Small Molecule NP/PA CME Bootcamp Series. For the last eight years, these consisted of one-day, quarterly educational Bootcamps with consistently updated content and discussion topics based on the latest available data, including discussion of atopic dermatitis (AD), psoriasis (Ps), and psoriatic arthritis (PsA), hidradenitis suppurativa (HS), alopecia areata, vitiligo, and urticaria.
We have updated these FREE CME programs in 2024 to increase our educational offerings and direct benefits to dermatology NPs and PAs, and ultimately, their patients. Within 2024, the DEF will host two (2) live in-person meetings and one (1) virtual meeting. Casting a keen eye on building the knowledge of the participants, the DEF will increase the immunology education with a focus on treatment targets and mechanism of action. In-depth immunology paired with case-based treatment discussions for initiation and management of inflammatory diseases will provide the training needed for dermatology NPs and PAs of all experience levels. Industry engagement and a strong focus on exploring specialty medication therapeutic options to maximize patient outcomes will allow attendees to better understand how to access these agents.
These meetings are tentatively scheduled to occur on the following dates in these cities:
Saturday, November 9, 2024 – Huntington Beach, CA*
Sunday, December 1, 2024 – Virtual Advanced Program*
Our faculty, April Armstrong, MD, MPH, Kara Gooding, MS, PA-C, Joe Gorelick, MSN, FNP-C, and Andrea Nguyen, MPAS, PA-C, present live in-person content with interactive discussion. Content is intended for NPs, PAs, biologic coordinators, MAs, and physicians.
Agenda Highlights include:
Immunology and Clinical Trial Review
Atopic Dermatitis, Psoriasis, Psoriatic Arthritis, Alopecia Areata, Vitiligo, and Chronic Spontaneous Urticaria Therapeutic Updates
Selecting the Right Patient for Initiation or Switching to a Biologic and Small Molecule Agent
Understanding the Role of Biosimilars
Calling all Practice Managers, Medical Assistants, and Biologic Coordinators for Specialty Pharmaceutical Access Sessions
Visual Diagnosis Challenges, Surveys, and More!
